Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Lasagna Reeves, Cristian A ^a,c   Castillo Carranza, Diana L ^a   Sengupta, Urmi ^a   Guerrero Munoz, Marcos J ^a   Kiritoshi, Takaki ^b   Neugebauer, Volker ^b   Jackson, George R ^a,b   Kayed, Rakez ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; BRAIN CORTEX; CHEMICAL PHENOMENA; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CYTOLOGY; DRUG EFFECT; EXCITATORY POSTSYNAPTIC POTENTIAL; GENETICS; HIPPOCAMPUS; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; LONG TERM POTENTIATION; MEMORY; METABOLISM; MOUSE; NERVE CELL; PATHOLOGY; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; SOLUTION AND SOLUBILITY; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; CEREBRAL CORTEX; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INJECTIONS, INTRAVENTRICULAR; LONG-TERM POTENTIATION; MEMORY; MICE; MICE, TRANSGENIC; NEURONS; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; RECOMBINANT PROTEINS; SOLUTIONS; TAU PROTEINS;

EID: 84868269943     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00700     Document Type: Article

References (58)

1. Brundin, P., Melki, R. & Kopito, R. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 11, 301-307 (2010).
2. Frost, B. & Diamond, M. I. Prion-like mechanisms in neurodegenerative diseases. Nat Rev Neurosci 11, 155-159 (2010).
3. Meyer-Luehmann, M. et al. Exogenous induction of cerebral beta-Amyloidogenesis is governed by agent and host. Science 313, 1781-1784 (2006). (Pubitemid 44454153)
4. Eisele, Y. S. et al. Peripherally applied Abeta-containing inoculates induce cerebral beta-Amyloidosis. Science 330, 980-982 (2010).
5. Clavaguera, F. et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11, 909-913 (2009).
6. Liu, L. et al. Trans-synaptic spread of tau pathology in vivo. PLoS One 7, e31302 (2012).
7. de Calignon, A. et al. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73, 685-697 (2012).
8. Kosik, K. S., Orecchio, L. D., Bakalis, S. & Neve, R. L. Developmentally regulated expression of specific tau sequences. Neuron 2, 1389-1397 (1989).
9. Giasson, B. I. et al. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 300, 636-640 (2003). (Pubitemid 36520587)
10. Kurt, M. A., Davies, D. C., Kidd, M., Duff, K. & Howlett, D. R. Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Neurobiol Dis 14, 89-97 (2003). (Pubitemid 37103183)
11. Sydow, A. et al. Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant. J Neurosci 31, 2511-2525 (2011).
12. Roberson, E. D. et al. Reducingendogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316, 750-754 (2007). (Pubitemid 46717684)
13. Vossel, K. A. et al. Tau reduction prevents Abeta-induced defects in axonal transport. Science 330, 198 (2010).
14. Nussbaum, J. M. et al. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta. Nature 485, 651-655 (2012).
15. Haass, C. & Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8, 101-112 (2007). (Pubitemid 46432529)
16. Caughey, B., Baron, G. S., Chesebro, B. & Jeffrey, M. Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions. Annu Rev Biochem 78, 177-204 (2009).
17. Kayed, R. et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489 (2003). (Pubitemid 36444329)
18. Lasagna-Reeves, C. A. et al. Identification of oligomers at early stages of tau aggregation in Alzheimer's disease. FASEB J 26, 1946-1959 (2012).
19. Patterson, K. R. et al. Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease. J Biol Chem 286, 23063-23076 (2011).
20. Langer, F. et al. Soluble Abeta seeds are potent inducers of cerebral beta-Amyloid deposition. J Neurosci 31, 14488-14495 (2011).
21. Lasagna-Reeves, C. A. et al. Identification of oligomers at early stages of tau aggregation in Alzheimer's disease. FASEB J 26, 1946-1959 (2012).
22. Lasagna-Reeves, C. A. et al. Tau oligomers impair memory and induce synaptic and mitochondrial dysfunctionin wild-type mice. Mol Neurodegener 6, 39(2011).
23. Lasagna-Reeves, C. A., Castillo-Carranza, D. L., Guerrero-Muoz, M. J., Jackson, G. R. & Kayed, R. Preparation and characterization of neurotoxic tau oligomers. Biochemistry 49, 10039-10041 (2010).
24. Prusiner, S. B. Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144 (1982). (Pubitemid 12089840)
25. Prusiner, S. B. et al. Evidence for hydrophobic domains on the surface of the scrapie agent. Trans Am Neurol Assoc 103, 62-64 (1978).
26. Rostagno, A. & Ghiso, J. Isolation and biochemical characterization of amyloid plaques and paired helical filaments. Curr Protoc Cell Biol Chapter 3, 1-33 (2009).
27. Guo, J. L. & Lee, V. M. Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem 286, 15317-15331 (2011).
28. Kfoury, N., Holmes, B. B., Jiang, H., Holtzman, D. M. & Diamond, M. I. Trans-cellular propagation of Tau aggregation by fibrillar species. J Biol Chem 287, 1440-1451 (2012).
29. Berger, Z. et al. Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J Neurosci 27, 3650-3662 (2007). (Pubitemid 46557687)
30. Spires, T. L. et al. Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. Am J Pathol 168, 1598-1607 (2006).
31. Jarrett, J. T., Berger, E. P. & Lansbury, P. T. Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32, 4693-4697 (1993). (Pubitemid 23162022)
32. Kelly, J. W. Mechanisms of amyloidogenesis. Nat Struct Biol 7, 824-826 (2000).
33. O'Nuallain, B., Williams, A. D., Westermark, P. & Wetzel, R. Seeding specificity in amyloid growth induced by heterologous fibrils. J Biol Chem 279, 17490-17499 (2004). (Pubitemid 38560512)
34. Dinkel, P. D., Siddiqua, A., Huynh, H., Shah, M. & Margittai, M. Variations in filament conformation dictate seeding barrier between three-And four-repeat tau. Biochemistry 50, 4330-4336 (2011).
35. Margittai, M. & Langen, R. Template-Assisted filament growth by parallel stacking of tau. Proc Natl Acad Sci USA 101, 10278-10283 (2004). (Pubitemid 38924916)
36. Siddiqua, A. & Margittai, M. Three-And four-repeat Tau coassemble into heterogeneous filaments: an implication for Alzheimer disease. J Biol Chem 285, 37920-37926 (2010).
37. Lee, J., Culyba, E. K., Powers, E. T. & Kelly, J. W. Amyloid-beta forms fibrils by nucleated conformational conversion of oligomers. Nat Chem Biol 7, 602-609 (2011).
38. Kayed, R. et al. Conformation dependent monoclonal antibodies distinguish different replicating strains or conformers of prefibrillar Abeta oligomers. Mol Neurodegener 5, 57 (2010).
39. Serio, T. R. et al. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289, 1317-1321 (2000). (Pubitemid 30656041)
40. Congdon, E. E. et al. Nucleation-dependent tau filament formation: The importance of dimerization and an estimation of elementary rate constants. J Biol Chem 283, 13806-13816 (2008).
41. Dineley, K. T. et al. Amyloid-beta oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice. J Neurosci Res 88, 2923-2932 (2012).
42. Cao, G. & Harris, K. M. Developmental regulation of the late phase of long-term potentiation (L-LTP) and metaplasticity in hippocampal area CA1 of the rat. J Neurophysiol 107, 902-912 (2012).
43. Tucker, K. L., Meyer, M. & Barde, Y. A. Neurotrophins are required for nerve growth during development. Nat Neurosci 4, 29-37 (2001).
44. Balducci, C. et al. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc Natl Acad Sci USA 107, 2295-2300 (2010).
45. Greene, J. D., Baddeley, A. D. & Hodges, J. R. Analysis of the episodic memory deficit in early Alzheimer's disease: evidence from the doors and people test. Neuropsychologia 34, 537-551 (1996). (Pubitemid 26154491)
46. Gallyas, F., Guldner, F. H., Zoltay, G. & Wolff, J. R. Golgi-like demonstration of "dark" neurons with an argyrophil III method for experimental neuropathology. Acta Neuropathol 79, 620-628 (1990). (Pubitemid 20170338)
47. LeVine, H. 3rd. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol 309, 274-284 (1999).
48. Augustinack, J. C., Schneider, A., Mandelkow, E. M. & Hyman, B. T. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol 103, 26-35 (2002). (Pubitemid 36075309)
49. Prusiner, S. B. Cell biology. A unifying role for prions in neurodegenerative diseases. Science 336, 1511-1513 (2012).
50. Morsch, R., Simon, W. & Coleman, P. D. Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol 58, 188-197 (1999). (Pubitemid 29088942)
51. Braak, H. & Del Tredici, K. The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol 121, 171-181 (2011).
52. Duyckaerts, C. Tau pathology in children and young adults: can you still be unconditionally baptist? Acta Neuropathol 121, 145-147 (2011).
53. Hardy, J. & Revesz, T. The spread of neurodegenerative disease. N Engl J Med 366, 2126-2128 (2012).
54. Silveira, J. R. et al. The most infectious prion protein particles. Nature 437, 257-261 (2005). (Pubitemid 41294488)
55. Collinge, J. & Clarke, A. R. A general model of prion strains and their pathogenicity. Science 318, 930-936 (2007). (Pubitemid 350098981)
56. Li, J., Browning, S., Mahal, S. P., Oelschlegel, A. M. & Weissmann, C. Darwinian evolution of prions in cell culture. Science 327, 869-872 (2010).
57. Polymenidou, M. & Cleveland, D. W. The seeds of neurodegeneration: prion-like spreading in ALS. Cell 147, 498-508 (2011).
58. Munch, C. & Bertolotti, A. Propagation of the prion phenomenon: beyond the seeding principle. J Mol Biol 421, 491-498 (2012).